CytoMed Therapeutics Limited (GDTC)
NASDAQ: GDTC · IEX Real-Time Price · USD
2.100
-0.140 (-6.25%)
Jul 19, 2024, 4:00 PM EDT - Market closed
CytoMed Therapeutics Market Cap
CytoMed Therapeutics has a market cap or net worth of $24.24 million as of July 22, 2024. Its market cap has decreased by -35.54% in one year.
Market Cap
24.24M
Enterprise Value
17.88M
1-Year Change
-35.54%
Ranking
Category
Stock Price
$2.10
Market Cap Chart
Since the IPO on April 14, 2023, CytoMed Therapeutics's market cap has decreased from $46.12M to $24.24M, a decrease of -47.45%. That is a compound annual growth rate of -39.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 24.20M | -57.17% |
| Dec 29, 2023 | 56.50M | 22.51% |
View and export this data all the way back to 2023.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NRx Pharmaceuticals | 24.93M |
| Accelerate Diagnostics | 24.70M |
| Meihua International Medical Technologies Co. | 24.44M |
| Trinity Biotech | 24.42M |
| Unity Biotechnology | 24.34M |
| Femasys | 24.22M |
| Akso Health Group | 24.01M |
| Cocrystal Pharma | 23.91M |